2hs1: Difference between revisions

Revision as of 18:50, 27 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2hs1.png

Template:STRUCTURE 2hs1

Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir) inhibitorUltra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir) inhibitor

Template:ABSTRACT PUBMED 16962136

About this StructureAbout this Structure

2HS1 is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

ReferenceReference

Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114., Kovalevsky AY, Liu F, Leshchenko S, Ghosh AK, Louis JM, Harrison RW, Weber IT, J Mol Biol. 2006 Oct 13;363(1):161-73. Epub 2006 Aug 4. PMID:16962136

Page seeded by OCA on Sun Jul 27 18:50:46 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2hs1.gif|left|200px]]
+{{Seed}}
+[[Image:2hs1.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2hs1|  PDB=2hs1  |  SCENE=  }}
-'''Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir) inhibitor'''
+===Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir) inhibitor===
-==Overview==
+<!--
-TMC114 (darunavir) is a promising clinical inhibitor of HIV-1 protease (PR) for treatment of drug resistant HIV/AIDS. We report the ultra-high 0.84 A resolution crystal structure of the TMC114 complex with PR containing the drug-resistant mutation V32I (PR(V32I)), and the 1.22 A resolution structure of a complex with PR(M46L). These structures show TMC114 bound at two distinct sites, one in the active-site cavity and the second on the surface of one of the flexible flaps in the PR dimer. Remarkably, TMC114 binds at these two sites simultaneously in two diastereomers related by inversion of the sulfonamide nitrogen. Moreover, the flap site is shaped to accommodate the diastereomer with the S-enantiomeric nitrogen rather than the one with the R-enantiomeric nitrogen. The existence of the second binding site and two diastereomers suggest a mechanism for the high effectiveness of TMC114 on drug-resistant HIV and the potential design of new inhibitors.
+The line below this paragraph, {{ABSTRACT_PUBMED_16962136}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 16962136 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_16962136}}
 ==About this Structure==
@@ Line 26: / Line 30: @@
 [[Category: Weber, I T.]]
 [[Category: Ultra-high resolution active site surface binding site]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 06:38:40 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 18:50:46 2008''